Needham analyst Rajvindra Gill maintains Cerence (NASDAQ:CRNC) with a Buy and lowers the price target from $78 to $46.
HeartBeam Granted Patent For 12-Lead Electrocardiogram (ECG) Patch Monitor Intended For Detection Of Heart Attacks And Complex Cardiac Arrhythmias
HeartBeam, Inc. (NASDAQ:BEAT), a cardiac technology company that has developed the first and only 3D-vector ECG platform for heart attack detection anytime, anywhere, announced today that its patent for a 12-lead
